AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 87 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,718 | -94.2% | 2,860 | -50.0% | 0.00% | -100.0% |
| Q2 2023 | $29,859 | +4.5% | 5,720 | +100.0% | 0.00% | 0.0% |
| Q1 2023 | $28,571 | +98420.7% | 2,860 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $29 | -99.9% | 2,860 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $29,000 | 0.0% | 2,860 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $29,000 | -50.8% | 2,860 | -51.0% | 0.00% | 0.0% |
| Q1 2022 | $59,000 | +321.4% | 5,840 | +96.0% | 0.00% | – |
| Q4 2021 | $14,000 | -41.7% | 2,980 | 0.0% | 0.00% | – |
| Q3 2021 | $24,000 | -11.1% | 2,980 | -25.1% | 0.00% | -100.0% |
| Q2 2021 | $27,000 | -3.6% | 3,980 | +14.4% | 0.00% | 0.0% |
| Q1 2021 | $28,000 | +40.0% | 3,480 | +40.3% | 0.00% | 0.0% |
| Q4 2020 | $20,000 | +11.1% | 2,480 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $18,000 | -21.7% | 2,480 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $23,000 | +43.8% | 2,480 | -16.8% | 0.00% | 0.0% |
| Q1 2020 | $16,000 | -20.0% | 2,980 | +20.2% | 0.00% | 0.0% |
| Q4 2019 | $20,000 | +5.3% | 2,480 | 0.0% | 0.00% | +100.0% |
| Q3 2019 | $19,000 | +1800.0% | 2,480 | +1966.7% | 0.00% | – |
| Q4 2018 | $1,000 | -80.0% | 120 | -76.0% | 0.00% | – |
| Q2 2018 | $5,000 | +66.7% | 500 | 0.0% | 0.00% | – |
| Q1 2018 | $3,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q4 2017 | $3,000 | -78.6% | 500 | -82.5% | 0.00% | -100.0% |
| Q3 2017 | $14,000 | +27.3% | 2,860 | 0.0% | 0.00% | – |
| Q2 2017 | $11,000 | -47.6% | 2,860 | 0.0% | 0.00% | -100.0% |
| Q1 2017 | $21,000 | +75.0% | 2,860 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $12,000 | -33.3% | 2,860 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $18,000 | – | 2,860 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Yu Fan | 112,044 | $891,000 | 15.31% |
| Aisling Capital Management LP | 1,691,151 | $13,445,000 | 2.68% |
| GREAT POINT PARTNERS LLC | 900,000 | $7,155,000 | 1.67% |
| Bain Capital Life Sciences Investors, LLC | 2,847,689 | $22,639,000 | 1.40% |
| Altium Capital Management LP | 609,689 | $4,847,000 | 1.27% |
| Sio Capital Management, LLC | 446,000 | $3,546,000 | 1.13% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 245,678 | $1,953,000 | 1.12% |
| Samsara BioCapital, LLC | 883,720 | $7,026,000 | 1.10% |
| Lion Point Capital, LP | 300,000 | $2,385,000 | 0.45% |
| Abingworth LLP | 240,500 | $1,912,000 | 0.43% |